DSCAM and breast carcinoma: Following the research conducted by Liu et al. (2002), Miano et al. (2016) have reported DSCAM-AS1 as the most abundant Apo−Estrogen Receptor α−regulated lncRNA in MCF−7 breast cancer cells.